Are you interested in the entrepreneur Calvin Knowlton’s financial success? Knowlton has created waves in a variety of areas as a well-known businessman and visionary, accumulating substantial money in the process. Knowlton’s financial success has attracted a lot of attention thanks to his innovative projects and wise investments.
Learn the fascinating facts about Calvin Knowlton’s net worth and explore the elements that have influenced his enviable financial situation.
Calvin Knowlton Net Worth
Calvin H Knowlton’s estimated net worth is at least $4 million. According to his Linkedin Profile, he is The CEO of Tabula Rasa HealthCare Inc, Calvin H Knowlton, is the owner of around 693,213 shares of the company’s stock, which is worth over $4 million. The Latest Holdings Summary part of Calvin H Knowlton contains more information.
What is Calvin H. Knowlton’s salary?
Dr. Knowlton received $5,971,425.00 in total pay as the CEO of Tabula Rasa HealthCare, Inc. in 2021. Dr. Knowlton received a $539,423 salary, $5,229,000 in stock awards, $181,500 in non-equity compensation, and $21,502 in other compensation.
What is Calvin Knowlton’s Past Insider Trading?
On November 14, 2018, Calvin Knowlton placed his largest purchase order for 7,500 units, totaling approximately $487,53K. On November 11, 2021, Calvin Knowlton received a sell order for 393,055 units, totaling more than $5.44M.
Calvin Knowlton has worked for Tabula Rasa Healthcare, Inc. for six years and has completed around 106 deals in total. Calvin Knowlton typically does business in February and November, with 2019 being the busiest year. On December 27, 2021, a selling order for 20,000 units valued at more than $296.4K was made.
Has Calvin H. Knowlton been buying or selling shares of Tabula Rasa HealthCare?
During the previous ninety days, Calvin H. Knowlton has not engaged in any active trading in Tabula Rasa HealthCare shares. Calvin H. Knowlton most recently sold 46,672 shares of the company’s stock in a transaction on November 17th. The shares were sold for an average price of $12.95, amounting to a $604,402.40 transaction.
Check out the articles given below to read more about the fortunes of various stars:
- Javier Castellano Net Worth: Exploring His Lucrative Income
- Jim Brown Net Worth: Exploring the Income and Accomplishments of a Sports Legend
- Carlo Ancelotti Net Worth: How Much Does He Earn From Career?
Calvin Knowlton Career
In his 30-year career, Dr. Knowlton has won multiple accolades for his leadership in pharmacy, business, and philanthropy, including the 2003 and 2013 Ernest and Young Entrepreneur of the Year Award, Greater Philadelphia Region, and the 2004 Walter M. Aikman Award.
1997’s Most Influential U.S. Pharmacist. He was elected national president of the American College of Apothecaries, two-term president of the American Pharmacists Association (APhA), and foundation president. He is on the Coriell Institute for Medical Research and Evergreens Continuing Care Retirement Community boards.
He chairs the Coriell Life Sciences, Inc. and Rowan University Cooper Medical School boards. He chairs Moorestown’s First Presbyterian Church’s Long Range Planning Panel and is on the Session. He recently left Philadelphia’s St. Christopher’s Hospital for Children Board. The FDA-recognized National Pharmacogenomics Advisory Group and the APhA Pharmacogenomics Task Force include him.
Knowlton founded CareKinesis, the first national PACE Medication Risk Mitigation Company. His eleventh firm is CareKinesis. Hospice Pharmacia was his last company before CareKinesis. His firms employed over 1,300 pharmacists, technicians, and administrators. Since 2010, CareKinesis has been shown by:
- Technology Innovator, Large Company, 2014 SmartCEO Voltage Award
- Healthcare Sector E&Y Entrepreneur of the Year, Greater Philadelphia Region, 2013
- The 2013 Garden State Entrepreneur Excellence Award
- Philadelphia Business Journal’s 2012 List of the best workplaces
- 2012 Growth Company of the Year: NJ Technology Council
- 2012’s IMPACT, Featured Company
- Life Science Start-up Company of the Year, 2011 Enterprise Awards, Greater Philadelphia Alliance for Capital and Technologies
Knowlton earned his doctorate in pharmacoeconomics from the University of Maryland, his pharmacy degree from Temple University, and his divinity degree from Princeton Theological Seminary. In the 1990s, he held the positions of professor and department chair at the University of the Sciences in Philadelphia.
Textbooks, book chapters, and articles he has written or co-written have all dealt with the function and accountability of pharmacists in the results of patient-centered medication care.